These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 2573340
1. Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation? Meinertz T, Drexler H, Just H. Basic Res Cardiol; 1989; 84 Suppl 1():177-86. PubMed ID: 2573340 [Abstract] [Full Text] [Related]
2. [Dopexamine: a new dopaminergic agonist]. Perrin G, Papazian L, Martin C. Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685 [Abstract] [Full Text] [Related]
4. Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure. Baumann G, Gutting M, Pfafferott C, Ningel K, Klein G. Eur Heart J; 1988 May 01; 9(5):503-12. PubMed ID: 3402466 [Abstract] [Full Text] [Related]
5. Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failure. Svensson G, Sjögren A, Erhardt L. Eur Heart J; 1986 Aug 01; 7(8):697-703. PubMed ID: 2876894 [Abstract] [Full Text] [Related]
6. Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure. Tan LB, Littler WA, Murray RG. Int J Cardiol; 1991 Feb 01; 30(2):203-8. PubMed ID: 2010243 [Abstract] [Full Text] [Related]
7. Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency. Fitton A, Benfield P. Drugs; 1990 Feb 01; 39(2):308-30. PubMed ID: 1970288 [Abstract] [Full Text] [Related]
8. Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure. Vincent JL, Reuse C, Kahn RJ. Chest; 1989 Dec 01; 96(6):1233-6. PubMed ID: 2573484 [Abstract] [Full Text] [Related]
9. Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study. Gollub SB, Elkayam U, Young JB, Miller LW, Haffey KA. J Am Coll Cardiol; 1991 Aug 01; 18(2):383-90. PubMed ID: 1677368 [Abstract] [Full Text] [Related]
10. Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output. Baumann G, Felix SB, Filcek SA. Am J Cardiol; 1990 Mar 15; 65(11):748-54. PubMed ID: 1969223 [Abstract] [Full Text] [Related]
11. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine. Jaski BE, Peters C. Am J Cardiol; 1988 Aug 11; 62(5):63C-67C. PubMed ID: 3407597 [Abstract] [Full Text] [Related]
12. Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine. Stephan H, Sonntag H, Henning H, Yoshimine K. Br J Anaesth; 1990 Sep 11; 65(3):380-7. PubMed ID: 1977432 [Abstract] [Full Text] [Related]